Search results
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via AOL· 2 days ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights Moderna to hold its Annual General Meeting on 6th of May CEO Stephane Bancel's total...
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 2 days agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 2 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 2 days agoModerna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells...
Moderna posts quarterly sales beat, smaller loss than expected
Reuters via Yahoo Finance· 2 days ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 2 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 2 days agoSales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the previous year to $167 million for the quarter but surpassed analysts’ expectations ...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 2 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.